SCHEMBL5574637

SCHEMBL5574637

NC(=O)NC(=O)c1ccccc1N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FADS1 O60427 3/20 0.54
ALDH1A1 P00352 7/20 0.52
HSD17B10 Q99714 2/20 0.52
CFTR P13569 1/20 0.52
PTGS1 P23219 2/20 0.51
KDM4E B2RXH2 6/20 0.50
P2RX1 P51575 1/20 0.50
NPC1 O15118 4/20 0.49
RAB9A P51151 4/20 0.49
GAA P10253 3/20 0.48
MAPT P10636 2/20 0.48
HPGD P15428 3/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
PIK3CA P42336 1/20 0.46
POLB P06746 1/20 0.45
MAPK1 P28482 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28193055 0.84 ALDH1A1 (0.48) FADS1ALDH1A1HSD17B10CFTRPTGS1
SCHEMBL8634908 0.84 RAB9A (0.50) FADS1ALDH1A1HSD17B10CFTRPTGS1
SCHEMBL30385607 0.83 KDM4E (0.55) FADS1ALDH1A1HSD17B10CFTRPTGS1
SCHEMBL6999516 0.82 ALDH1A1 (0.55) FADS1ALDH1A1HSD17B10CFTRPTGS1
SCHEMBL7160814 0.81 CYP3A4 (0.53) ALDH1A1KDM4ENPC1GAAMAPT
SCHEMBL9921278 0.80 KDM4E (0.60) FADS1ALDH1A1HSD17B10CFTRPTGS1
SCHEMBL5807531 0.80 MAPT (0.60) FADS1ALDH1A1HSD17B10CFTRPTGS1
SCHEMBL11589554 0.79 ALDH1A1 (0.42) ALDH1A1KDM4ENPC1MAPTHPGD
SCHEMBL11743614 0.79 NPC1 (0.72) FADS1ALDH1A1HSD17B10CFTRPTGS1
SCHEMBL17744848 0.79 PTGS1 (0.75) FADS1ALDH1A1HSD17B10PTGS1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070003987-A1 Screening method for substance binding to merozoite surface protein-1/42 MEDICAL RESEARCH COUNCIL (GB) 2007-01-04 US disclosed
EP-1634079-A1 SCREENING METHOD FOR SUBSTANCES BINDING TO MEROZOITE SURFACE PROTEIN-1/42 MEDICAL RESEARCH COUNCIL (GB) 2006-03-15 EP disclosed
WO-2004113920-A1 SCREENING METHOD FOR SUBSTANCES BINDING TO MEROZOITE SURFACE PROTEIN-1/42 MEDICAL RESEARCH COUNCIL (GB) 2004-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070003987-A1 Screening method for substance binding to merozoite surface protein-1/42 CD2BP2, MASP2, CD14 FADS1 4798/4885ALDH1A1 3620/4885HSD17B10 4047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.